Mycophenolate Mofetil Selection of Gene Modified T Cells With an Engineered Human Inosine Monophosphate Dehydrogenase II (IMPDH2)

被引：0
|
作者：
Jonnalagadda, Mahesh [1 ]
Chang, Wen-Chung [1 ]
Jensen, Michael C. [1 ]
机构：
[1] City Hope Natl Med Ctr, Beckman Res Inst, Duarte, CA 91010 USA
来源：
JOURNAL OF IMMUNOTHERAPY | 2008年 / 31卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：923 / 923
页数：1
相关论文
共 34 条
  • [21] Overexpression of Inosine 5′-Monophosphate Dehydrogenase Type II Mediates Chemoresistance to Human Osteosarcoma Cells
    Fellenberg, Joerg
    Kunz, Pierre
    Saehr, Heiner
    Depeweg, Daniela
    PLOS ONE, 2010, 5 (08):
  • [22] Regulation of inosine-5'-monophosphate dehydrogenase type II gene expression in human T cells - Role for a novel 5' palindromic octamer sequence
    Zimmermann, AG
    Wright, KL
    Ting, JPY
    Mitchell, BS
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (36) : 22913 - 22923
  • [23] Engineering Human T Cells for Resistance to Methotrexate and Mycophenolate Mofetil as an In Vivo Cell Selection Strategy
    Jonnalagadda, Mahesh
    Brown, Christine E.
    Chang, Wen-Chung
    Ostberg, Julie R.
    Forman, Stephen J.
    Jensen, Michael C.
    PLOS ONE, 2013, 8 (06):
  • [24] In Vivo Selection of Gene Modified T Cells Using Engineered Human Enzymes Resistant to Clinical Immunosuppressive Drugs
    Jonnalagadda, Mahesh
    Chang, Wen-Chung
    Jensen, Michael
    MOLECULAR THERAPY, 2009, 17 : S218 - S219
  • [25] Selection in NOD-scid IL2Rγnull Mice of Gene-Modified Human T Cells Expressing Engineered Human Enzymes that Confer Resistance to Lymphotoxic Drugs
    Jonnalagadda, M.
    Brown, C. E.
    Chang, W. C.
    Ostberg, J.
    Forman, S. J.
    Jensen, M. C.
    JOURNAL OF THE AMERICAN ASSOCIATION FOR LABORATORY ANIMAL SCIENCE, 2011, 50 (05): : 803 - 804
  • [26] Ex vivo selection and expansion of cells based on expression of a mutated inosine monophosphate dehydrogenase 2 after HIV vector transduction:: Effects on lymphocytes, monocytes, and CD34+ stem cells
    Yam, Priscilla
    Jensen, Michael
    Akkina, Ramesh
    Anderson, Joseph
    Villacres, Maria C.
    Wu, Jerry
    Zaia, John A.
    Yee, Jiing-Kuan
    MOLECULAR THERAPY, 2006, 14 (02) : 236 - 244
  • [27] Specific inhibition of Type II inosine monophosphate dehydrogenase activity of Tmolt4 T cell human leukaemia cells by 3-methoxy and di-benzohydroxamic acids, maleic hydrazide and malonic acids
    Hall, IH
    Barnes, BJ
    Ward, ES
    Wheaton, JR
    Izydore, RA
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2001, 53 (05) : 749 - 755
  • [28] Increased IL-6 and TNF-α production of T helper 1 and 2 cells in cyclosporin plus mycophenolate mofetil treated human heart transplant recipients.
    Barten, MJ
    Rahmel, A
    Richter, M
    Bittner, HB
    Dhein, S
    Mohr, FW
    Gummert, JF
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 173 - 173
  • [29] Improved targeting of human CD4+ T cells by nanobody-modified AAV2 gene therapy vectors
    Hamann, Martin, V
    Beschorner, Niklas
    Vu, Xuan-Khang
    Hauber, Ilona
    Lange, Ulrike C.
    Traenkle, Bjoern
    Kaiser, Philipp D.
    Foth, Daniel
    Schneider, Carola
    Buning, Hildegard
    Rothbauer, Ulrich
    Hauber, Joachim
    PLOS ONE, 2021, 16 (12):
  • [30] Retroviral-mediated gene transfer in human primary T lymphocytes induces an activation- and transduction/selection-dependent TCRBV repertoire skewing of gene-modified cells.
    Coito, S
    Sauce, D
    Duperrier, A
    Certoux, JM
    Bonyhadi, M
    Collette, A
    Kuehlcke, K
    Hervé, P
    Tiberghien, P
    Robinet, E
    Ferrand, C
    BLOOD, 2002, 100 (11) : 650A - 650A
1234